| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/23/2011 | US20110152173 TNF-a ANTAGONIST MULTI-TARGET BINDING PROTEINS |
| 06/23/2011 | US20110152169 Sparc anti-inflammatory activity and uses thereof |
| 06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 06/23/2011 | US20110151033 Orthosiphon stamineus extracts for use as a cognition enhancer |
| 06/23/2011 | US20110151024 Compositions and Methods for Preventing Migraines |
| 06/23/2011 | US20110151016 Use of angiogenin or angiogenin agonists for treating diseases and disorders |
| 06/23/2011 | US20110151008 Pulmonary Delivery for Levodopa |
| 06/23/2011 | US20110151002 Sustained release pharmaceutical compositions comprising quetiapine |
| 06/23/2011 | US20110150994 Modified Release Formulation |
| 06/23/2011 | US20110150991 Abuse resistant drugs, method of use and method of making |
| 06/23/2011 | US20110150990 Abuse resistant drugs, method of use and method of making |
| 06/23/2011 | US20110150989 Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans |
| 06/23/2011 | US20110150981 Compounds for Use in Therapy |
| 06/23/2011 | US20110150980 Cgrp analog |
| 06/23/2011 | US20110150946 Transdermal Delivery of Apomorphine Using Microneedles |
| 06/23/2011 | US20110150894 Methods of modulating angiogenesis via trpv4 |
| 06/23/2011 | US20110150893 Anti-trkb monoclonal antibodies and uses thereof |
| 06/23/2011 | US20110150873 Anti-inflammatory compositions and combinations |
| 06/23/2011 | US20110150860 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
| 06/23/2011 | US20110150834 Crth2 modulators |
| 06/23/2011 | US20110150833 Benzopyrans and analogs as rho kinase inhibitors |
| 06/23/2011 | US20110150822 Pheromone compositions and methods of use |
| 06/23/2011 | US20110150781 Tissue kallikrein for the treatment of parkinson's disease |
| 06/23/2011 | US20110150769 Identification and use of compounds for treating persistent pain |
| 06/23/2011 | US20110150766 Transdermal patch with fatal overdose protection |
| 06/23/2011 | CA2785064A1 Prostate specific membrane antigen inhibitors |
| 06/23/2011 | CA2784830A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| 06/23/2011 | CA2784712A1 Percutaneous absorption preparation comprising anti-dementia drug |
| 06/23/2011 | CA2784091A1 Use of a neurofilament peptide for the treatment of glioma |
| 06/23/2011 | CA2783728A1 Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors |
| 06/23/2011 | CA2783726A1 Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors |
| 06/23/2011 | CA2783556A1 Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases |
| 06/23/2011 | CA2782950A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors |
| 06/23/2011 | CA2782947A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors |
| 06/23/2011 | CA2782361A1 Bridgehead amine ring-fused indoles and indolines useful to treat neurodegenerative and neuropsychiatric disorders |
| 06/23/2011 | CA2781495A1 Pyrrolidine derivatives |
| 06/23/2011 | CA2780290A1 Mk2 inhibitors |
| 06/23/2011 | CA2780155A1 Ethynyl derivatives |
| 06/22/2011 | EP2336368A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/22/2011 | EP2336321A1 Ox2 receptor homolog |
| 06/22/2011 | EP2336301A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336300A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336299A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336297A2 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 06/22/2011 | EP2336190A2 Anti-VEGF antibodies |
| 06/22/2011 | EP2336184A2 Administration of agents for the treatment of inflammation |
| 06/22/2011 | EP2336167A1 MHC molecule constructs and their uses for diagnosis and therapy |
| 06/22/2011 | EP2336136A1 Pyridine derivatives and their use in the treatment of psychotic disorders |
| 06/22/2011 | EP2336129A1 1-aza-bicyclo[3.3.1]nonanes |
| 06/22/2011 | EP2336128A1 Benzoisothiazoles and preparation and uses thereof |
| 06/22/2011 | EP2336111A1 Heterocyclic inhibitors of p38 |
| 06/22/2011 | EP2336109A1 Novel pyrrolinone derivative and medicinal composition containing same |
| 06/22/2011 | EP2336105A1 Nitrogen-containing heterocyclic compound and use of same |
| 06/22/2011 | EP2335726A1 Fusion molecules and methods for treatment of immune diseases |
| 06/22/2011 | EP2335720A1 Autologous T-cell vaccines materials and methods |
| 06/22/2011 | EP2335701A1 Heterocyclic aspartyl protease inhibitors |
| 06/22/2011 | EP2335699A1 Synergistic combination of analgesic compounds |
| 06/22/2011 | EP2335494A1 Method for concentrating lipid |
| 06/22/2011 | EP2334684A1 Pyrazolopyrimidines and their use for the treatment of cns disorders |
| 06/22/2011 | EP2334665A1 Modulators for amyloid beta |
| 06/22/2011 | EP2334657A1 Piperazine d3 and 5-ht2a receptor modulators |
| 06/22/2011 | EP2334644A1 Pyridinylpiperazin derivatives useful as modulators of dopamine d3 receptors |
| 06/22/2011 | EP2334326A2 Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders |
| 06/22/2011 | EP2334297A1 Lofexidine enantiomers for use as a treatment for cns disease and pathologies and its chiral synthesis |
| 06/22/2011 | EP2334293A2 Compositions comprising polyhydroxyltate fatty alcohol derivatives and the therapeutic uses |
| 06/22/2011 | EP2334185A1 Compositions and methods of using (r)-pramipexole |
| 06/22/2011 | EP2334181A1 Phthalimide derivative metabotropic glutamate r4 ligands |
| 06/22/2011 | EP2334180A1 Alleviating disorders with combining agents that increase epoxygenated fatty acids and agents that increase camp |
| 06/22/2011 | EP2252591B1 Aryl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
| 06/22/2011 | EP2203422B1 Phenylpyrrolidine compounds |
| 06/22/2011 | EP2155674B1 Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands |
| 06/22/2011 | EP2146714B1 Use of 4-cyclopropylmethoxy-<i>n</i>-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of motor disorders related to parkinson's disease |
| 06/22/2011 | EP1912979B1 Phenyl-{3-(3-(1h-pyrrol-2-yl)-[1,2,4]oxadiazol-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 06/22/2011 | EP1324771B1 Therapeutic and tolerance inducing antibodies |
| 06/22/2011 | CN1984905B Constrained himbacine analogs as thrombin receptor antagonists |
| 06/22/2011 | CN1900076B Tetrahydro proto-berberine compounds, and their preparing method and use |
| 06/22/2011 | CN1898244B Triazole derivatives as vasopressin antagonists |
| 06/22/2011 | CN1887309B Extraction of effective red sage components for preventing and treating osteoporosis and depression |
| 06/22/2011 | CN1809570B [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 06/22/2011 | CN1701073B Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 06/22/2011 | CN102105475A Spiroaminodihydrothiazine derivatives |
| 06/22/2011 | CN102105466A Isoxazole derivatives and their use as metabotropic glutamate receptor potentiators |
| 06/22/2011 | CN102105465A Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof |
| 06/22/2011 | CN102105458A 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as NK1 receptor antagonists |
| 06/22/2011 | CN102105456A Aryl-sulphonamidic dimers as metalloproteases inhibitors |
| 06/22/2011 | CN102105452A Substituted carbinol compound having cyclic linker |
| 06/22/2011 | CN102105448A Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states |
| 06/22/2011 | CN102105437A Adamantyl diamide derivatives and uses of same |
| 06/22/2011 | CN102105173A Glycerophospholipids for the improvement of cognitive functions |
| 06/22/2011 | CN102105169A Pharmaceutical compositions for treatment of parkinson's disease |
| 06/22/2011 | CN102105168A Therapeutic agent for migraine |
| 06/22/2011 | CN102102114A Preparation of pregabalin and related compounds |
| 06/22/2011 | CN102101863A Novel epoxy thiazone compounds and preparation method and application thereof |
| 06/22/2011 | CN102101836A New crystal form of S-oxiracetam and preparation method thereof |
| 06/22/2011 | CN102100913A Target spot and medicine for treating cerebral injury |
| 06/22/2011 | CN102100897A Preparation technology and preparation method of novel integrative Erchen decoction dosage form |
| 06/22/2011 | CN102100893A Preparation technology of new integrative formulation of five accumulations powder and production method thereof |
| 06/22/2011 | CN102100892A Preparation technology and production method of integrated Xiaojianzhong decoction novel dosage form |
| 06/22/2011 | CN102100890A Preparation technology of new integrative formulation of cassia twig decoction and production method thereof |
| 06/22/2011 | CN102100889A Preparation technology of new integrative formulation of spleen-returning decoction |